Finance

Lists
REMEDY:HEL
Remedy Entertainment Oyj
€15.10
+0.27%
(+0.040) 1D
Nov 17, 10:51:00 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for REMEDY...
Open
€15.04
High
€15.10
Low
€15.00
Mkt. cap
205.97M
Avg. vol.
16.95K
Volume
2.20K
52-wk high
€20.65
52-wk low
€11.06
EPS
-€0.18
Shares outstanding
13.64M
No. of employees
378
Open
€15.04
High
€15.10
Low
€15.00
Mkt. cap
205.97M
Avg. vol.
16.95K
Volume
2.20K
52-wk high
€20.65
52-wk low
€11.06
EPS
-€0.18
Shares outstanding
13.64M
No. of employees
378
News stories
From web sources and news partners
Profile
Remedy Entertainment Oyj, trading internationally as Remedy Entertainment Plc, is a Finnish video game developer based in Espoo. Notable games the studio has developed include the first two entries in the Max Payne franchise, Alan Wake, Quantum Break, and Control. Sam Lake, Remedy's creative director, has represented the company on numerous occasions. Founded in August 1995 by members of demoscene group Future Crew, Remedy Entertainment created its first game, Death Rally, in a team member's basement. Apogee Software served as the game's publisher, and continued to be involved in the production of its next title, Max Payne, which received critical acclaim upon release. The game was followed by a sequel, Max Payne 2: The Fall of Max Payne, released by Rockstar Games. After spending seven years working on the Max Payne franchise, the developer decided to create a new intellectual property called Alan Wake. This title was once suspected to be vaporware because of the length of time it took to produce and release. It gained a cult following when it was released in 2010, by Microsoft Game Studios, though at the time its sales were not enough to justify the production of a sequel. Wikipedia
About Remedy Entertainment Oyj
CEO-
Employees378
FoundedAug 18, 1995
Headquarters-
SectorCommunication Services
Industry-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
17.04M
13.14M
10.16M
39.63M
Cost of goods sold
4.23M
907.00K
1.15M
1.03M
Cost of revenue
4.23M
907.00K
1.15M
1.03M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.52M
6.34M
6.74M
4.99M
Operating expense
-2.83M
11.20M
12.95M
38.02M
Total operating expenses
1.40M
12.11M
14.10M
39.06M
Operating income
15.64M
1.03M
-3.94M
578.00K
Other non operating income
621.00K
-
-1.00K
-154.00K
EBT including unusual items
453.00K
752.00K
-3.91M
-35.00K
EBT excluding unusual items
15.37M
752.00K
-3.91M
-35.00K
Income tax expense
52.00K
276.00K
-668.00K
65.00K
Effective tax rate
11.48%
36.70%
17.08%
-185.71%
Other operating expenses
-565.00K
2.96M
4.66M
26.85M
Net income
401.00K
476.00K
-3.24M
-100.00K
Net profit margin
2.35%
3.62%
-31.94%
-0.25%
Earnings per share
0.03
0.04
-0.24
-0.01
Interest and investment income
40.00K
13.00K
488.00K
-
Interest expense
-703.00K
-290.00K
-455.00K
-459.00K
Net interest expenses
-663.00K
-277.00K
33.00K
-459.00K
Depreciation and amortization charges
-11.78M
1.90M
1.55M
6.19M
EBITDA
16.15M
1.51M
-3.46M
2.10M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps